Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate CancerCameron Herberts, Alexander W. Wyatt, Elena Schönlau et al.|European Urology|2020Cited by 90
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancerPier‐Luc Clermont, Cheryl D. Helgason, Francesco Crea et al.|Clinical Epigenetics|2016Cited by 78